Analysis of the Pathogenic Variants of Genes Using a Gene Panel in Turkish Epilepsy Patients
dc.contributor.author | Gun-Bilgic D. | |
dc.contributor.author | Polat M. | |
dc.date.accessioned | 2024-07-22T08:04:31Z | |
dc.date.available | 2024-07-22T08:04:31Z | |
dc.date.issued | 2022 | |
dc.description.abstract | Background: Epilepsy is a neurological disease that is mostly caused by genetic factors. The genetic diagnosis of patients in a pediatric epilepsy cohort was provided. Methods: After phenotypic characterization, a 48-gene Next Generation Sequencing panel was performed in 110 Turkish children with epilepsy. The variants were called and annotated using the QIAGEN Ingenuity® Variant Analysis software. Results: Of those carrying pathogenic mutations, two patients had mutations in the SCN1A gene and two patients in the TSC2 gene; other patients had mutations in the SCN1B, GRIN2B, KCNQ2, PCDH19, CHRNA2, and MECP2 genes. In total, nine out of 10 patients had pathogenic variants that were not previously reported. Conclusions: The genotype-phenotype correlations of these variants were discussed by comparing the clinical find-ings with the literature. © 2022 Verlag Klinisches Labor GmbH. All rights reserved. | |
dc.identifier.DOI-ID | 10.7754/Clin.Lab.2021.210939 | |
dc.identifier.issn | 14336510 | |
dc.identifier.uri | http://akademikarsiv.cbu.edu.tr:4000/handle/123456789/12737 | |
dc.language.iso | English | |
dc.publisher | Verlag Klinisches Labor GmbH | |
dc.subject | Cadherins | |
dc.subject | Child | |
dc.subject | Cohort Studies | |
dc.subject | Epilepsy | |
dc.subject | Genetic Association Studies | |
dc.subject | High-Throughput Nucleotide Sequencing | |
dc.subject | Humans | |
dc.subject | Mutation | |
dc.subject | Phenotype | |
dc.subject | Protocadherins | |
dc.subject | methyl CpG binding protein 2 | |
dc.subject | n methyl dextro aspartic acid receptor 2B | |
dc.subject | potassium channel KCNQ2 | |
dc.subject | sodium channel Nav1.1 | |
dc.subject | tuberin | |
dc.subject | voltage gated sodium channel beta 1 subunit | |
dc.subject | cadherin | |
dc.subject | PCDH19 protein, human | |
dc.subject | adolescent | |
dc.subject | allele | |
dc.subject | Article | |
dc.subject | child | |
dc.subject | chrna2 gene | |
dc.subject | cohort analysis | |
dc.subject | epilepsy | |
dc.subject | epileptic patient | |
dc.subject | female | |
dc.subject | gene | |
dc.subject | gene mutation | |
dc.subject | genetic variability | |
dc.subject | high throughput sequencing | |
dc.subject | human | |
dc.subject | major clinical study | |
dc.subject | male | |
dc.subject | motor retardation | |
dc.subject | pcdh19 gene | |
dc.subject | phenotype | |
dc.subject | preschool child | |
dc.subject | school child | |
dc.subject | epilepsy | |
dc.subject | genetic association study | |
dc.subject | genetics | |
dc.subject | high throughput sequencing | |
dc.subject | mutation | |
dc.title | Analysis of the Pathogenic Variants of Genes Using a Gene Panel in Turkish Epilepsy Patients | |
dc.type | Article |